Mortality risk in post-operative head and neck cancer patients during the SARS-Cov2 pandemic: early experiences

Eur Arch Otorhinolaryngol. 2021 Jan;278(1):275-278. doi: 10.1007/s00405-020-06138-w. Epub 2020 Jun 22.

Abstract

Purpose: The objective of this report is to outline our early experience with head and neck cancer patients in a tertiary referral center, during the SARS-Cov2 pandemic, and to describe the poor outcomes of patients who acquired the infection.

Methods: In this case series from a single-center, national tertiary referral center for head and neck cancer we describe three consecutive head and neck cancer patients who contracted SARS-Cov2 during their inpatient stay.

Results: Of the three patients described in our case series that contracted SARS-Cov2, two patients died from SARS-Cov2 related illness.

Conclusion: We have demonstrated the significant implications that SARS-Cov2 has on head and neck cancer patients, with 3 patients acquiring SARS-Cov2 in hospital, and 2 deaths in our that cohort. We propose a complete separation in the location of where these patients are being managed, and also dedicated non-SARS-Cov2 staff for their peri-operative management.

Level of evidence: IV.

Keywords: Covid-19; Head and neck cancer; Mortality; SARS-Cov2.

MeSH terms

  • COVID-19*
  • Cohort Studies
  • Head and Neck Neoplasms / mortality*
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / surgery
  • Humans
  • Male
  • Pandemics
  • Postoperative Complications / mortality
  • Postoperative Complications / virology*
  • SARS-CoV-2
  • Tertiary Care Centers